Bottom Line: Active surveillance of men with low-risk prostate cancer may be better for quality of life and is cost-effective compared with immediate treatment, reports a study published today in CMAJ Open. Prostate Cancer: Prostate cancer is the most common cancer in Canadian men and the third leading cause of death from cancer. The incidence of … Continue reading Watching, Delaying Treatment Of Low-Risk Prostate Cancer May Be More Cost-Effective Approach
Bottom Line: Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function, according to a study in the April 2 issue of JAMA. Background: Erectile dysfunction (ED) is a common condition resulting from many causes, including prostate cancer treatment. An … Continue reading Medication Does Not Help Prevent Erectile Dysfunction Following Radiation Therapy for Prostate Cancer
The U.S. Food and Drug Administration has approved a new advanced drug Xofigo (radium Ra 223 dichloride) for the treatment of symptomatic late-stage (metastatic) castration-resistant prostate cancer that has not yet targeted any other organs of the body instead of bones.
Risk of prostate cancer is two times higher in men with sleep problems according to the latest study published in the journal of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
CNIO researchers, together with scientists in the United Kingdom, have revealed that hereditary mutations in the BRCA2 gene predispose patients to a worse evolution of the illness and a greater risk of developing metastasis
All types of prostate cancers including aggressive tumor could be effectively treated be using certain compounds present in grape skins and red wine, according to the latest research published in the journal of Andrology and Cancer Science.
Risk of death in men suffering from prostate cancer could be increased by metabolic factors according to the latest research published in the journal of Cancer, a peer-reviewed journal of the American Cancer Society. Certain common symptoms of metabolic syndrome alter blood sugar, blood pressure, body mass index and blood lipids.
Most aggressive type of prostate cancer can be detected by using barcode blood test as shown by latest research published in the Lancet Oncology journal. This test could select which patients of prostate cancer require immediate treatment by determining the pattern of genes switched on and switched off in blood samples as suggested by staff … Continue reading Aggressive Prostate Cancer May Be Detected By Barcode Blood Test
A new gene based prostate cancer test could reduce the chances of painful repeat biopsies that can cause some serious infections as shown by latest research to be published in the November issue of the Journal of Urology.
Latest research which was published in New England Journal of Medicine (NEJM) has shown that survival of prostate cancer patients could be increased by using Enzalutamide. It has been estimated that 241,740 men will suffer and 28,170 men will be died due to prostate cancer in 2012.